Akishi Ooi Selected Research

Akishi Ooi Research Topics

Disease

40	Neoplasms (Cancer) 01/2021 - 01/2002
20	Carcinoma (Carcinomatosis) 06/2020 - 04/2002
9	Stomach Neoplasms (Stomach Cancer) 01/2017 - 04/2002
7	Breast Neoplasms (Breast Cancer) 05/2021 - 01/2002
7	Adenocarcinoma 04/2014 - 04/2002
7	Neoplasm Metastasis (Metastasis) 01/2010 - 01/2003
4	Sarcoma (Soft Tissue Sarcoma) 01/2013 - 01/2006
4	Colorectal Neoplasms (Colorectal Cancer) 12/2012 - 09/2003
4	Lymphatic Metastasis 09/2005 - 01/2003
3	Esophageal Squamous Cell Carcinoma 11/2015 - 07/2005
3	Osteosarcoma (Osteogenic Sarcoma) 08/2014 - 08/2011
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
2	Cholangiocarcinoma 09/2013 - 11/2012
2	Carcinogenesis 01/2009 - 01/2004
2	Malignant Fibrous Histiocytoma 06/2007 - 12/2004
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2020
1	Ganglion Cysts (Ganglion) 09/2018
1	Diabetes Mellitus 02/2018
1	Hyperglycemia 02/2018
1	Multiple Myeloma 02/2018
1	Thyroid Diseases (Thyroid Disease) 05/2015
1	Lobular Carcinoma 05/2014
1	Ductal Carcinoma 05/2014
1	Malignant Mesothelioma 01/2014
1	Glioma (Gliomas) 07/2013
1	Glioblastoma (Glioblastoma Multiforme) 07/2013
1	Myxoid Liposarcoma 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 11/2012
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 11/2012
1	Margins of Excision 08/2011
1	Adrenocortical Carcinoma 01/2010
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2010

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2002
11	ParaffinIBA 01/2019 - 01/2002
11	ErbB Receptors (EGF Receptor)IBA 09/2012 - 11/2003
10	Formaldehyde (Formol)FDA Link 01/2019 - 01/2002
4	Phosphotransferases (Kinase)IBA 01/2020 - 11/2003
4	Monoclonal AntibodiesIBA 04/2014 - 04/2002
4	TOR Serine-Threonine KinasesIBA 09/2012 - 01/2009
4	fibroblast activation protein alphaIBA 09/2005 - 01/2003
4	GelatinasesIBA 09/2005 - 01/2003
4	Serine Proteases (Serine Protease)IBA 09/2005 - 01/2003
3	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 11/2003
3	Cyclin D1IBA 01/2018 - 07/2004
3	Protein Kinases (Protein Kinase)IBA 06/2007 - 12/2004
3	Trastuzumab (Herceptin)FDA Link 07/2005 - 04/2002
3	ErbB-2 ReceptorIBA 07/2002 - 01/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2020 - 11/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017 - 12/2003
2	Protein Isoforms (Isoforms)IBA 06/2015 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2014
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 09/2013 - 11/2012
2	Peptide Initiation Factors (Initiation Factor)IBA 02/2011 - 10/2009
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2010 - 07/2005
2	DNA (Deoxyribonucleic Acid)IBA 08/2004 - 07/2004
1	LigandsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 06/2020
1	Transforming Growth Factor-beta Type I ReceptorIBA 06/2020
1	Estrogen ReceptorsIBA 06/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	I-kappa B KinaseIBA 01/2019
1	ChromatinIBA 09/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2018
1	Insulin (Novolin)FDA Link 02/2018
1	Lenalidomide (CC 5013)FDA Link 02/2018
1	Bortezomib (Velcade)FDA Link 02/2018
1	Clarithromycin (Biaxin)FDA LinkGeneric 02/2018
1	Cyclin EIBA 01/2017
1	UbiquitinIBA 01/2017
1	Ligases (Synthetase)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 10/2016
1	human ERBB2 proteinIBA 01/2015
1	Cadherins (E-Cadherin)IBA 05/2014
1	DesminIBA 01/2014
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2013
1	MethyltransferasesIBA 07/2013
1	ElementsIBA 12/2012
1	NucleotidesIBA 12/2012
1	Fetal Proteins (Fetoprotein)IBA 11/2012
1	GlypicansIBA 11/2012
1	Epithelial Cell Adhesion MoleculeIBA 11/2012
1	Ribosomal Protein S6IBA 02/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010
1	AntibodiesIBA 11/2010
1	Platelet-Derived Growth FactorIBA 11/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2010

Therapy/Procedure

16	Therapeutics 01/2019 - 04/2002
11	Drug Therapy (Chemotherapy) 01/2015 - 11/2003
8	Ligation 01/2020 - 04/2014
1	Radiotherapy 01/2020
1	Molecular Targeted Therapy 01/2020
1	Punctures 09/2018
1	Combination Drug Therapy (Combination Chemotherapy) 02/2018
1	Operative Surgical Procedures 05/2015
1	Distraction Osteogenesis 08/2014
1	Neoadjuvant Therapy 04/2014
1	Chemoradiotherapy 07/2013